HoD Office, Level 6, West Wing, John Radcliffe Hospital
Strategic Initiatives Manager
James leads strategic projects across the Nuffield Department of Clinical Neurosciences. These include the Research Excellence Framework, outside appointments/partnerships, conflict of interest, research governance, compliance, data privacy and information security, environmental sustainability, and equality, diversity and inclusivity.
Before joining NDCN late 2022, James spent six years as a Senior Clinical Trial Manager in Sir Peter Horby's group at the Pandemic Sciences Institute, Nuffield Department of Medicine.
James has worked in a Research Governance capacity (with the Research Governance, Ethics and Assurance Team) for University of Oxford sponsored studies, which included monitoring of clinical trials and supporting high-quality research within the University. He had previous coordinating roles at the Oxford Biomedical Research Centre and the Radiology department at the Churchill Hospital.
James is also a qualified exercise therapist and has undertaken research on the effects of exercise on the behavioural and psychological symptoms of dementia.
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
ISARIC Clinical Characterization Group None. et al, (2022), Sci Data, 9
Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
Wainstein M. et al, (2022), PLoS Med, 19
Importance of patient bed pathways and length of stay differences in predicting COVID-19 hospital bed occupancy in England
Leclerc QJ. et al, (2021), BMC Health Services Research, 21
The value of open-source clinical science in pandemic response: lessons from ISARIC
Abbas A. et al, (2021), The Lancet Infectious Diseases, 21, 1623 - 1624
A prenylated dsRNA sensor protects against severe COVID-19
Wickenhagen A. et al, (2021), Science, 374